Neuroprotective effects of fingolimod in mouse models of Parkinson's disease.
Zhao P, Yang X, Yang L, Li M, Wood K, Liu Q, Zhu X.
Zhao P, et al. Among authors: li m.
FASEB J. 2017 Jan;31(1):172-179. doi: 10.1096/fj.201600751R. Epub 2016 Sep 26.
FASEB J. 2017.
PMID: 27671228
These findings suggest the potential of S1PR modulation as a treatment for PD.-Zhao, P., Yang, X., Yang, L., Li, M., Wood, K., Liu, Q., Zhu, X. Neuroprotective effects of fingolimod in mouse models of Parkinson's disease....
These findings suggest the potential of S1PR modulation as a treatment for PD.-Zhao, P., Yang, X., Yang, L., Li, M., Wood, K., …